Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARVINAS, INC. Director's Dealing 2021

Aug 16, 2021

32625_dirs_2021-08-16_d7bbd181-0334-4950-91b0-6347bed782b5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARVINAS, INC. (ARVN)
CIK: 0001655759
Period of Report: 2021-08-12

Reporting Person: Peck Ronald (Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-12 Common Stock M 4011 Acquired 6765 Direct
2021-08-12 Common Stock S 1363 $90.5351 Disposed 5402 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-08-12 Restricted Stock Units $ M 4011 Disposed Common Stock (4011) Direct

Footnotes

F1: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.

F2: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.

F3: On July 29, 2019, the reporting person was granted 16,041 Restricted Stock Units, vesting in four equal annual installments beginning July 29, 2020.